- Home
- AVNW vs CATX Comparison
AVNW vs CATX Comparison
Compare AVNW & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVNW
- CATX
- Stock Information
- Founded
- AVNW 2006
- CATX 1983
- Country
- AVNW United States
- CATX United States
- Employees
- AVNW N/A
- CATX N/A
- Industry
- AVNW Radio And Television Broadcasting And Communications Equipment
- CATX Medical/Dental Instruments
- Sector
- AVNW Technology
- CATX Health Care
- Exchange
- AVNW Nasdaq
- CATX Nasdaq
- Market Cap
- AVNW 291.3M
- CATX 239.0M
- IPO Year
- AVNW 2007
- CATX N/A
- Fundamental
- Price
- AVNW $22.83
- CATX $3.81
- Analyst Decision
- AVNW Strong Buy
- CATX Strong Buy
- Analyst Count
- AVNW 5
- CATX 11
- Target Price
- AVNW $37.60
- CATX $12.90
- AVG Volume (30 Days)
- AVNW 81.1K
- CATX 700.3K
- Earning Date
- AVNW 10-03-2025
- CATX 08-13-2025
- Dividend Yield
- AVNW N/A
- CATX N/A
- EPS Growth
- AVNW N/A
- CATX N/A
- EPS
- AVNW N/A
- CATX N/A
- Revenue
- AVNW $435,926,000.00
- CATX $1,235,000.00
- Revenue This Year
- AVNW $8.50
- CATX N/A
- Revenue Next Year
- AVNW $5.18
- CATX $11.99
- P/E Ratio
- AVNW N/A
- CATX N/A
- Revenue Growth
- AVNW 14.58
- CATX N/A
- 52 Week Low
- AVNW $12.96
- CATX $1.60
- 52 Week High
- AVNW $28.37
- CATX $16.55
- Technical
- Relative Strength Index (RSI)
- AVNW 53.16
- CATX 49.56
- Support Level
- AVNW $20.81
- CATX $3.47
- Resistance Level
- AVNW $22.08
- CATX $3.94
- Average True Range (ATR)
- AVNW 0.76
- CATX 0.26
- MACD
- AVNW 0.04
- CATX -0.04
- Stochastic Oscillator
- AVNW 69.68
- CATX 41.98
About AVNW Aviat Networks Inc.
Aviat Networks Inc is a networking solutions provider. It designs, manufactures and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.